Human Immunodeficiency Virus

Recent advancements in cancer research have shed light on the intricate relationship between Human Immunodeficiency Virus (HIV) and certain types of cancer. HIV, by weakening the immune system, increases susceptibility to various cancers, including Kaposi's sarcoma, non-Hodgkin lymphoma, and cervical cancer. Understanding the molecular mechanisms underlying this association has become pivotal in developing targeted therapies. Researchers are investigating how HIV proteins interact with cellular pathways involved in cancer development and progression. Additionally, they explore the impact of antiretroviral therapy on cancer risk among HIV-positive individuals. This interdisciplinary approach holds promise in not only elucidating the pathogenesis of HIV-associated cancers but also in devising more effective treatment strategies tailored to this vulnerable population.